Cellectar Biosciences Inc (CLRB)

Cellectar Biosciences Inc (CLRB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.1M; returns 1 day +4.3%, 1 week +7.0%, 1 year -67.7%.

Cellectar Biosciences Inc. (CLRB) is a late-stage clinical biopharmaceutical and radiopharmaceutical company primarily focused on the discovery and development of proprietary cancer treatments. The company's core strategy revolves around its unique Phospholipid Drug Conjugate (PDC™) delivery platform.

Groups CLRB belongs to

• Biotechnology
• Biopharmaceutical
• Oncology
• Healthcare
• Clinical Stage Biotech
• Cancer Therapeutics
• Clinical Stage
• Life Sciences
• Precision Medicine
• Antibody-Drug Conjugates
• Rare Diseases
• Hematologic Malignancies
• Fast Track Designation

CLRB financial model: income statement, cash flow and balance sheet